(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-Carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid

Term ID

CHEBI:181227

Synonyms

(2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid

Definition

References

Chemspider:22842382

Ontology

ChEBI ( EBI )

Relationships

is a type of: triterpenoid

triterpenoid Show first 5 Terms

Phenotype

Phenotype resulting from (2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-Carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid

Phenotype where environments contain (2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-Carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid

Phenotype modified by environments containing (2R,6R)-6-[(3R,10S,12S,13R,17R)-3-(2-Carboxyacetyl)oxy-12-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-methylideneheptanoic acid

Human Disease / Model Data